Found 26 matching trials
A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors PHASE1 This is a Phase 1/1b open-label study evaluating the safety, pharmacokineti...
Show More Status
Active Not Recruiting
Location
Scottsdale Healthcare /ID# 123761
Learn More & Join Trial
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC PHASE1 This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Show More Learn More & Join Trial
Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC PHASE1 This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Show More Learn More & Join Trial
BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations PHASE1 This is an open-label, non-randomized, multi-cohort, multi-center Phase Ia/...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS PHASE2 The objective of this Phase II, open-label, multicenter, non-randomised con...
Show More Location
Multiple Locations
Learn More & Join Trial
G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer PHASE1 This was a study to investigate the potential clinical benefit of G1T38 as ...
Show More Location
Beverly Hills Cancer Center
Learn More & Join Trial
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer PHASE2 The trial consists of a series of parallel multi-centre single arm phase II...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial
A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib. EARLY_PHASE1 The purpose of this study is to assess whether dacomitinib after osimertini...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer PHASE1 Protocol Title
A Study to Evaluate ANS014004 in Combination with EGFR-TKI ...
Show More Location
Memorial Sloan Kettering Cancer Center David H, Koch Center lor Cancer Care
Learn More & Join Trial
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients N/A The goal of the study is to collect data on patients treated outside of a c...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial